Evaluation of Antioxidants in Bone Mineral Density of Iranian Osteoporotic Women

Document Type : Original Article


1 Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

2 Food and Drug Laboratory Research Center, Ministry of Health and Medical Education, Tehran, Iran

3 Pharmacotherapy Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

4 Drug and Food Control Department, Faculty of Pharmacy, Jondishapoor University of Medical Sciences, Ahvaz, Iran


Bone is a dynamic tissue that is continuously renewed throughout life by the process of bone remodeling. Antioxidant system might be involved in the pathogenesis of bone loss, so the aim of this study was to evaluate the total antioxidant capacity (TAC), vitamin C and vitamin E levels of plasma besides measuring enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT) and glutathione reductase (GR) enzymes activity in Iranian osteoporotic women comparing to the control group.
Materials and Methods
Bone mineral density (BMD) of the femoral neck and lumbar spine was measured by dual x-ray absorptiometry. The participants were divided into groups: a) total participants (-3.9 ≤ T–score ≤ 3.6) including 192 women, b) the control group (T-score ≥ -1) including 76 women, c) the total patients (T-score < -1) including 76 women. Then, plasma TAC, vitamin C levels, SOD and GR activities, erythrocyte CAT were measured using spectrophotometrical methods separately, and for vitamin E by HPLC analysis.
Comparing the control group and osteoporotic women showed that: a) plasma levels for vitamin C and erythrocyte CAT were markedly lower in the patients than in the controls, but plasma activity of TAC, SOD and GR were significantly higher, respectively. b) the differences were higher between control and patients with severe disease (T-score <-1.7) comparing to patients in the group with milder disease (-1.7 ≤ T-score <-1). c) Femoral neck BMD adjusted with age and BMI showed a positive and significant correlation with plasma levels of vitamin C in all subjects, but this relation was reverse or negative for TAC, SOD and GR.
It seems that a physiologic increase in the amount of some antioxidants occurs in osteoporosis; even though this amount may not be sufficient for the human body requirements.


1. Thomas E, Andreoli Charles CJ, Carpenter RC, Griggs Jl. Cecil essentials of medicine. Philadelphia: W.B.Saunders Company; 2004.
2. Mundy GR. Bone Remodeling. In: MJ F.editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. New York: Lippincott, Williams & Wilkins;1999.p.30-38.
3. Chan GK, Duque G. Age-related bone loss: old bone, new facts. Gerontology 2002; 48:62-71.
4. The abstract book of the first international seminar on prevention, diagnosis and treatment of osteoporosis. Endocrinol Metab Res Center 2004; 23-24
5. Bartl R, Frisch B. Recognizing Risk Factors Osteoporosis: Diagnosis, prevention, therapy. New York: Springer- Verlag; 2004.
6. Rao LG. Will Tomatoes Prevent Osteoporosis? Endocrinology Rounds 2005; 5: 2.
7. Sahnoun Z, Jamoussi K, Zeghal KM. Free radicals and antioxidants:human physiology, pathology and therapeutic aspects. Therapie 1997; 52:251-270.
8. Knight JA.The biochemistry of aging .Adv Clin Chem 2000; 35:1-62.
9. McCormick RK.Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.. Alternative Medicine Review 2007; 12: 113-145.
10. Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 1999; 14:129-135.
11. Morton DJ, Barrett-Connor EL, Schneider DL.Vitamin C supplement and bone mineral density in postmenopausal women. J Bone Miner Res 2001; 16:135-140.
12. Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007; 295:45-52.
13. Fatokum AA, Stone TW, Smith RA . Response of different MC3T3-E1 osteoblast – like cells to reactive oxygen species. Eur J Pharm 2008; 587:35-41.
14. Benzie IFF, Strain JJ. The ferric reducing ability of plasma as a power: The FRAP assay. Anal Bio Chem 1999; 239:70-76.
15. Hajimahmoodi M, Mojtahedzadeh M, GhaffarNatanzi N, Sadrai S, Sadeghi N, Nadjafi A, et al. Effects of vitamin E administration on APACHE II Score in ARDS patients. Daru 2009; 17:24-28.
16. Chung WY, Chung JKO, Szeto YT, Tomlinson B, Benzie IFF.Plasma ascorbic acid: measurement, stability and clinical utility revisited. Clin Biochem 2001; 34: 623-627.
17. Aebi HE. Catalase:hydrogen-peroxide oxidoreductase. In:Bergmeyer HU, Bergmeryer J, Greassl M, editors. Methods of enzymatic analysis. Weinhemi: Verlag Chemie 1983.p. 273-285.
18. Elstner EF, Youngamn RJ, Osswld W. Superoxide dismutase. In: Bergmeyer HU, Bergmeryer J, Greassl M, ed. Methods of enzymatic analysis. Weinhemi: Verlag Chemie 1983.p.293-302.
19. Goldberg DM, Spooner RJ. Oxidoreductases acting on groups other than CHOH. Glutathione reductase.In: Bergmeyer HU, Bergmeyer J, Grassl M,editors.In Methods of Enzymatic Analysis.Verlag Chemie, Weinheim 1983.p.258-265.
20. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001; 288:275-279.
21. Sontakke AN, Tare RS. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 2002; 318:145-148.
22. Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi AR, Sajadian Z. Determination of plasma gluthatione reductase enzyme activity in osteoporotic women. Daru 2008; 19:51-54.
23. Behfar AA, Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi AR, et al. The plasma antioxidant activity of superoxide dismutase enzyme in osteoporosis. Acta Med Iran 2008; 46:441-446.
24. Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003; 88:1523-1527.
25. Bax BE, Alam AS, Banerji B.Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 19992; 183:1153-1158.
26. Suda N, Morita I, Kuroda T, Murota S.Participation of oxidative stress in the process of osteoclast differentiation. Biochim Biophys Acta 1993; 1157:318-323.
27. Steinbeck MJ, Kim JK, Trudeau MJ, Hauschka PV, Karnovsky MJ. Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells. J Cell Physiol 1998; 176:574-587.
28. Nam SH, Jung SY, Yoo CM, Ahn EH, Suh CK. H2O2 enhances Ca2+ release from osteoblast internal stores. Yonsei Med J 2002; 43:229-235.
29. Darden AG, Ries WL, Wolf WC, Rodriguiz RM, Key LL. Osteoclastic superoxide production and bone resorption:stimulation and inhibition by modulators of NADPH oxidase. J Bone Miner Res 1996; 11:671-675.
30. Soo SJ, Lee KW, Rhee JS, Hwang DS, Lee YM, Park HG, et al. Environmental stressors (salinity, heavy metals and H2O2) modulate expression of glutathione reductase (G R) gene from theintertidal copepod tigriopus japonicus. Aquat Toxicol 2006; 80:281-289.
31. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1999; 53:189-193.
32. Buttner GR, Jurkiewicz BA.Catalytic metals, Ascorbate and free radicals: Combinations to avoid. Radiat Res 1996; 145:532-541.
33. Roughead ZK, Kunkel ME. Effect of diet on bone matrix constituents. J Am Coll Nutr 1991; 10:242-246.
34. Franceschi RT. The role of ascorbic acid in mesenchymal differentaion. Nutr Rev 1992; 50:65-70.
35. Francesschi R, Iyer B. Relationship between collgen synthesis and expression of the ostesblast phenotype in Mc3T3-E1 cells. J Bone Miner Res 1992; 7:235-246.
36. Ostalowska A, Birkner E, Wiecha M, Kasperczyk S, Kasperczyk A, Kapolka D, et al. Lipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthritis Cartilage 2006; 14:139-145.
37. Sacheck JM, Blumberg JB. Role of vitamin E and oxidative stress in exercise. Nutrition 2001; 17:809-814.
38. Wolf RL, Cauley JA, Pettinger M, Jackson R, Lacroix A, Leboff MS, et al. Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative.Am J Clin Nutr 2005; 82:581-588.
39. Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000; 31:2295-2300.
40. Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H. Profiles of antioxidants in human plasma. Free Radic Biol Med 2001; 30:456-462.
41. Kimura F, Hasegawa G, Obayashi H, Adachi T, Hara H, Ohta M, et al. Serum extracellular superoxide dismutase in patients with type 2 diabetes: relationship to the development of micro- and macro vascular complications. Diabetes Care 2003; 26:1246-1250.